teupolioside

putatively ameliorates colitis; isolated from Ajuga reptans; structure in first source

Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

1.	Caminiti, Rocco: 1 article (03/2009)
2.	Cuzzocrea, Salvatore: 1 article (03/2009)
3.	Dal Toso, Roberto: 1 article (03/2009)
4.	Di Paola, Rosanna: 1 article (03/2009)
5.	Esposito, Emanuela: 1 article (03/2009)
6.	Mazzon, Emanuela: 1 article (03/2009)
7.	Pressi, Giovanna: 1 article (03/2009)
8.	Riccardi, Luisa: 1 article (03/2009)

1.	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/01/2009 - "The results of this study suggested that administration of teupolioside may be beneficial for treatment of inflammatory bowel disease."
2.	Colitis 03/01/2009 - "The aim of the present study was to examine the effects of phenylpropanoid glycoside, teupolioside, biotechnologically produced by IRBN22 Ajuga reptans cell line, in rats subjected to experimental colitis. " 03/01/2009 - "Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis."
3.	Hyperandrogenism 01/01/2022 - "Taking into consideration wide-ranging pharmacological and biological properties and the safety of herbal extracts, we proposed a combination of curcumin and teupolioside to evaluate the anti-androgenic properties in women with PCOS and clinical signs of hyperandrogenism. "
4.	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/27/2022 - "Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study."
5.	Hirsutism 01/01/2022 - "Curcumin and Teupolioside attenuate signs and symptoms severity associated to hirsutism in PCOS women: a preliminary pilot study."